Sartorius Analysis (April 2026) | Price Development & Price Target

Sartorius

XTRA:SRT3

€ 211,90

€0,00 (0,00%)

211,90 €

€0,00 (0,00%)

End-of-day quote: 04/01/2026

Sartorius Stock Value

The analyst rating for Sartorius is currently Outperform.

Outperform

Sartorius Company Info

EPS Growth 5Y

5,75%

Market Cap

€13,15 B

Long-Term Debt

€4,02 B

Annual earnings

N/A

Dividend

€0,74

Dividend Yield

0,35%

Founded

1870

Industry

Health Care

Country

Germany

Website

Sartorius

ISIN Number

DE0007165631

Website

http://www.sartorius.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

€275,00

29.78%

Last Update: 04/01/2026

Analysts: 19

Highest Price Target €307,00

Average Price Target €275,00

Lowest Price Target €190,00

In the last five quarters, Sartorius’s Price Target has fallen from €320,66 to €320,50 - a -0,05% decrease. Twelve analysts predict that Sartorius’s share price will increase in the coming year, reaching €275,00. This would represent an increase of 29,78%.

Top growth stocks in the health care sector (5Y.)

What does Sartorius do?

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services. Business Segments The company operates through two primary business segments: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions This segment focuses on providing comprehensive products and services that support the development and manufacture of biopharmaceuticals. This segment includes: Cell Culture Media: Essential for the growth and maintenance of cells in the production of biol...

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services.

Business Segments

The company operates through two primary business segments: Bioprocess Solutions and Lab Products & Services.

Bioprocess Solutions

This segment focuses on providing comprehensive products and services that support the development and manufacture of biopharmaceuticals. This segment includes:

Cell Culture Media: Essential for the growth and maintenance of cells in the production of biologics.

Bioreactors: Used for cultivating cells and microorganisms under controlled conditions.

Membrane Chromatography: Facilitates the separation and purification of biomolecules.

Filtration Systems: Ensures the removal of contaminants from biopharmaceutical products.

Lab Products & Services

This segment offers a wide array of laboratory instruments, consumables, and services for research and quality assurance. This segment includes:

Laboratory Balances: Precision instruments for measuring mass in laboratory settings.

Pipettes: Tools for accurately measuring and transferring small volumes of liquid.

Lab Water Systems: Systems for producing pure and ultrapure water for laboratory use.

Business Strategy

The company's business strategy is centered on innovation, growth, and sustainability, aiming to solidify its position as a leading international partner in the life sciences research and biopharmaceutical industry.

Additional Offerings

The company provides various other products and services that cater to the needs of the life sciences and biopharmaceutical industries. These include:

IT/OT Data-Driven Solutions and Software: Advanced digital solutions that support data management and process optimization in laboratory and production environments.

Repair, Refurbishment, and Remanufacturing Services: Services aimed at extending the lifecycle of laboratory and production equipment, contributing to a circular economy.

Geographical Markets Served

The company serves a global market with a strong presence in key regions worldwide. The company operates a robust network of sales and service subsidiaries, as well as manufacturing facilities in Europe, Asia, and the Americas.

Customers

The company's customer base includes:

Biopharmaceutical Companies: These customers utilize the company's bioprocess solutions for the development and manufacture of biologics, vaccines, and other biopharmaceutical products.

Research Institutions: These include academic and governmental research laboratories that use the company's lab products and services for various research purposes.

Quality Assurance Laboratories: These customers rely on the company's laboratory instruments and consumables to ensure the quality and safety of products across different industries.

Marketing and Distribution Channels

The company employs various marketing and distribution channels to reach its customers. The company's marketing efforts include:

Direct Sales: The company engages directly with customers through its sales force, ensuring personalized service and support.

Digital Marketing: The company utilizes digital platforms to promote its products and services, providing customers with easy access to information and resources.

Trade Shows and Conferences: The company participates in industry events to showcase its latest innovations and connect with potential customers.

Partnerships and Collaborations: The company collaborates with other organizations to expand its reach and enhance its product offerings.

Regulations

Key areas of government regulation include:

Pharmaceutical and Biopharmaceutical Regulations: The company's bioprocess solutions must comply with stringent regulations set by health authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other national regulatory bodies.

Medical Device Regulations: The company's laboratory instruments and consumables are classified as medical devices in some jurisdictions and must comply with relevant regulations, including the Medical Device Regulation (MDR) in the European Union and the FDA's regulations in the United States.

Export and Import Controls: The company's global operations are subject to export and import controls, including compliance with international trade laws and sanctions.

Industry Standards

The company adheres to various industry standards to ensure the quality and safety of its products. These standards include:

Good Manufacturing Practices (GMP): The company's manufacturing processes comply with GMP guidelines, which are designed to ensure the quality and consistency of biopharmaceutical products.

ISO Standards: The company's laboratory instruments and consumables are manufactured in accordance with International Organization for Standardization (ISO) standards, including ISO 9001 for quality management systems and ISO 13485 for medical devices.

Environmental Regulations

The company adheres to various environmental laws and regulations, including:

Environmental Protection Regulations: The company complies with environmental protection regulations that govern emissions, waste management, and resource conservation.

Climate Change Regulations: The company is committed to reducing its greenhouse gas emissions and complying with climate change regulations.

Chemical Regulations: The company's products and manufacturing processes must comply with chemical regulations such as the European Union's Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulation and the U.S. Toxic Substances Control Act (TSCA). These regulations ensure the safe use and management of chemicals.

History

Sartorius Aktiengesellschaft was founded in 1870.

Sartorius Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenue distribution by industry:** - Biopharmaceutical industry: approx. 75% - Laboratory technology: approx. 25% **TOP 3 markets and their percentage shares:** - USA: approx. 35% - Europe (excluding Germany): approx. 30% - Germany: approx. 15% Sartorius Aktiengesellschaft generates the majorit...

At which locations are the company’s products manufactured?

**Production sites of Sartorius Aktiengesellschaft:** 1. **Göttingen, Germany** 2. **Aubagne, France** 3. **Beijing, China** 4. **Yauco, Puerto Rico** 5. **Tucson, USA** Sartorius Aktiengesellschaft is a globally active company specializing in the manufacturing of laboratory and process technology...

What strategy does Sartorius pursue for future growth?

**Revenue Growth:** Expected to be 8-10% annually (2025-2027, estimate) **Investment Volume:** Over 400 million euros annually (2025, estimate) Sartorius Aktiengesellschaft is pursuing a growth strategy based on several pillars. Firstly, the company is focusing on continuously expanding its produ...

Which raw materials are imported and from which countries?

**Main raw materials:** Cell culture media, filter membranes, plastic resins **Countries of origin:** USA, China, Germany Sartorius Aktiengesellschaft is a leading company in the biotechnology industry specializing in the manufacturing of laboratory and process technology. Among the main raw mate...

How strong is the company’s competitive advantage?

**Market Share:** Approximately 20% in the field of bioprocess solutions (2024, estimate) **Research and Development Ratio:** 8% of revenue (2024) **EBIT Margin:** 25% (2024) Sartorius Aktiengesellschaft has a significant competitive advantage in the field of bioprocess solutions, where the com...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** approx. 60% (estimated for 2025) **Insider Trades:** No specific data available for 2025 The institutional investor share in Sartorius Aktiengesellschaft traditionally remains at a high percentage, indicating the trust of large institutional investors in the comp...

What percentage market share does Sartorius have?

**Market Share of Sartorius AG:** Estimated 10-12% (2025) **Main Competitors and Their Market Shares:** 1. Thermo Fisher Scientific: approx. 15-17% 2. Danaher Corporation: approx. 13-15% 3. Merck KGaA: approx. 10-12% 4. Agilent Technologies: approx. 8-10% 5. Bio-Rad Laboratories: approx. 5-7% Sart...

Is Sartorius stock currently a good investment?

**Revenue Growth:** 10% (2024) **EBITDA Margin:** 33% (2024) **Research and Development Ratio:** 8% of revenue (2024) Sartorius Aktiengesellschaft recorded a revenue growth of 10% in 2024, driven by strong demand in the field of bioprocess solutions. The EBITDA margin of 33% demonstrates solid oper...

Does Sartorius pay a dividend – and how reliable is the payout?

**Dividend yield:** 0.6% (2025, estimated) **Dividend history:** Continuous payout over the last 5 years Sartorius Aktiengesellschaft has regularly distributed dividends in recent years. The dividend yield is currently around 0.6%, which is relatively low compared to other companies in the indu...

New support ticket

Explore

Sartorius Stock Value

Sartorius Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Sartorius do?

Sartorius Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Sartorius Stock Value

Sartorius Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Sartorius do?

Sartorius Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.